Abstract
References
- Shaffer E. Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006; 6: 981-6.
- Yoshida M, Hasegawa H, Norimizu S. Accuracy of the Tokyo Guidelines for the diagnosis of acutecholangitis and cholecystitis taking into consideration the clinical practice pattern in Japan. J Hepatobiliary Pancreat Sci 2011; 18: 250–7.
- Ateş B, Ünal İ. Kolesistit, Safra Taşları, Risk Faktörleri ve Beslenme İle İlişkisi. Güncel gastroenteroloji 2016; 20: 317-1.
- Laura M, Eldon A, Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut and Liver 2012; 2: 172-7.
- Menéndez-Sánchez P, León-Salinas C, Amo-Salas M, Méndez-Cea B, García-Carranza A.Association of laboratory and radiologic Parameters in the diagnosis of acute cholecystitis. Rev Gastroenterol Mex 2019; 84: 449-4.
- Pehlivan T, Alper Çevik A, Ateş E. Relationships among ultrasonographic and demographic, clinical, laboratory findings of patients with acute cholecystitis. Ulus Travma Acil Cerrahi Derg 2005; 11: 134-0.
- Shabanzadeh DM. Incidence of gallstone disease and complications. Curr Opin Gastroenterol 2018; 34: 81-9.
- Bonfrate L, Wang DQ, Garruti G, Portincasa P. Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Pract Res Clin Gastroenterol 2014; 28: 623-35.
- Constantinescu T, Huwood Al Jabouri AK, Brãtucu E, Olteanu C, Toma M, Stoiculescu A. Gallstone disease in young population: incidence, complications, therapeutic approach. Chirurgia (Bucur) 2012; 107: 579-82.
- Saleem Ansari, Hasan Haboubi, Nadim Haboubi. Adult obesity complications: challenges and clinical impact. Ther Adv Endocrinol Metab 2020; 11: 22
- Mendez Sanchez N, Chavez Tapia C, Motola Kuba D. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005: 11: 1653–7.
- Ata N, Kucukazman M, Yavuz B. The metabolic syndrome is associated with complicated gallstone disease. Can J-Gastroenterol 2010; 25: 274-6.
- Mutlu P, Mirici A, Gönlügür U, et al. Evaluating the clinical, radiological, microbiological, biochemical parameters and the treatment response in COVID-19 pneumonia. J Health Sci Med 2022: 5; 544–551
- Tang Y, Hu L, Liu Y, et al. Possible mechanisms of cholesterol elevation aggravating COVID-19. Int J Med Sci 2021; 18: 3533-43
- Uyaroğlu O, Murat Özdede M, Başaran N, et al. Hyperlipidemia in Post-COVID patients; a unique observational follow-up study on lipid levels in post-COVID patients. J Health Sci Med 2022; 5: 220 - 26.
- Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after COVID-19. Diabetologia 2022; 16:1-6.
Abstract
Aim: A gallstone is a stone formed within the gallbladder out of precipitated bile components. Risk factors for gallstones include a family history of gallstones, age, genetic and environmental factors, sedentary lifestyle, high-fat diet, obesity. In this study, it was aimed to determine the effects of the pandemic process on acute cholecystitis cases.
Material and Method: Patients who applied to hospital between 1st January 2018 and 1st January 2022 and were diagnosed with Acute Cholecystitis were retrospectively screened. The demographic data as age and sex were recorded by dividing the patients into two groups, two years before and two years after the COVID-19 pandemic period.
Results: The 2-year retrospective evaluation before and after the COVID-19 pandemic, a significant increase was found in cases of acute cholecystitis after the pandemic (p<0.05).
Conclusion: Sedentary lifestyle and obesity are important factors in the etiology of acute cholecystitis. The COVID-19 pandemic, an increase in the number of acute cholecystitis have been clearly demonstrated by this single center data.
Keywords
References
- Shaffer E. Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006; 6: 981-6.
- Yoshida M, Hasegawa H, Norimizu S. Accuracy of the Tokyo Guidelines for the diagnosis of acutecholangitis and cholecystitis taking into consideration the clinical practice pattern in Japan. J Hepatobiliary Pancreat Sci 2011; 18: 250–7.
- Ateş B, Ünal İ. Kolesistit, Safra Taşları, Risk Faktörleri ve Beslenme İle İlişkisi. Güncel gastroenteroloji 2016; 20: 317-1.
- Laura M, Eldon A, Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut and Liver 2012; 2: 172-7.
- Menéndez-Sánchez P, León-Salinas C, Amo-Salas M, Méndez-Cea B, García-Carranza A.Association of laboratory and radiologic Parameters in the diagnosis of acute cholecystitis. Rev Gastroenterol Mex 2019; 84: 449-4.
- Pehlivan T, Alper Çevik A, Ateş E. Relationships among ultrasonographic and demographic, clinical, laboratory findings of patients with acute cholecystitis. Ulus Travma Acil Cerrahi Derg 2005; 11: 134-0.
- Shabanzadeh DM. Incidence of gallstone disease and complications. Curr Opin Gastroenterol 2018; 34: 81-9.
- Bonfrate L, Wang DQ, Garruti G, Portincasa P. Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Pract Res Clin Gastroenterol 2014; 28: 623-35.
- Constantinescu T, Huwood Al Jabouri AK, Brãtucu E, Olteanu C, Toma M, Stoiculescu A. Gallstone disease in young population: incidence, complications, therapeutic approach. Chirurgia (Bucur) 2012; 107: 579-82.
- Saleem Ansari, Hasan Haboubi, Nadim Haboubi. Adult obesity complications: challenges and clinical impact. Ther Adv Endocrinol Metab 2020; 11: 22
- Mendez Sanchez N, Chavez Tapia C, Motola Kuba D. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005: 11: 1653–7.
- Ata N, Kucukazman M, Yavuz B. The metabolic syndrome is associated with complicated gallstone disease. Can J-Gastroenterol 2010; 25: 274-6.
- Mutlu P, Mirici A, Gönlügür U, et al. Evaluating the clinical, radiological, microbiological, biochemical parameters and the treatment response in COVID-19 pneumonia. J Health Sci Med 2022: 5; 544–551
- Tang Y, Hu L, Liu Y, et al. Possible mechanisms of cholesterol elevation aggravating COVID-19. Int J Med Sci 2021; 18: 3533-43
- Uyaroğlu O, Murat Özdede M, Başaran N, et al. Hyperlipidemia in Post-COVID patients; a unique observational follow-up study on lipid levels in post-COVID patients. J Health Sci Med 2022; 5: 220 - 26.
- Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after COVID-19. Diabetologia 2022; 16:1-6.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Original Article |
| Authors | |
| Publication Date | July 20, 2022 |
| Published in Issue | Year 2022 Volume: 5 Issue: 4 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
|
|
|
| |
|
|
|
|
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
|
|
|
|
|
|
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.